Literature DB >> 2744460

Differential requirements for cell-specific elastase I enhancer domains in transfected cells and transgenic mice.

G H Swift1, F Kruse, R J MacDonald, R E Hammer.   

Abstract

The 134-bp enhancer region of the pancreatic elastase I gene is sufficient to direct pancreatic acinar cell-specific transcription in transgenic mice and in transfected cells in culture. Ten-base-pair scanner mutations in three separate enhancer domains that inactivate enhancer function in transfected pancreatic cells in culture have no significant effect in transgenic mice. Because any pair of the three domains is sufficient to direct pancreas-specific expression in mice, no one domain is required for pancreas-specific transcription. Disruption of any two domains does inactivate the enhancer function in transgenic mice. Therefore, the elastase I enhancer domains essential for function in transfected cells in culture are not essential in animals but have a redundant function not apparent in transfected cells. This redundant function is not because of the particular acinar cell line used for transfections, the nature of the reporter gene, or the state of integration of the foreign test gene. We conclude that a trans-acting transcription factor or a modification of a factor(s) present in pancreatic cells of an animal is absent in pancreatic acinar cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744460     DOI: 10.1101/gad.3.5.687

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  21 in total

1.  The tissue-specific regulation of the carboxyl ester lipase gene in exocrine pancreas differs significantly between mouse and human.

Authors:  M Kannius-Janson; U Lidberg; G Bjursell; J Nilsson
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice.

Authors:  M K Short; D E Clouthier; I M Schaefer; R E Hammer; M A Magnuson; E G Beale
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Exocrine pancreas transcription factor 1 binds to a bipartite enhancer element and activates transcription of acinar genes.

Authors:  S L Weinrich; A Meister; W J Rutter
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice.

Authors:  D B Donoviel; M A Shield; J N Buskin; H S Haugen; C H Clegg; S D Hauschka
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Transcription factors binding to the mouse HTF9 housekeeping promoter differ between cell types.

Authors:  M P Somma; I Gambino; P Lavia
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

6.  The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein.

Authors:  A Krapp; M Knöfler; S Frutiger; G J Hughes; O Hagenbüchle; P K Wellauer
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Polyomavirus DNA replication in the pancreas and in a transformed pancreas cell line has distinct enhancer requirements.

Authors:  R Rochford; L P Villarreal
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  Functional redundancy of the DE-1 and alpha A-CRYBP1 regulatory sites of the mouse alpha A-crystallin promoter.

Authors:  C M Sax; J G Ilagan; J Piatigorsky
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

9.  Restriction of neuroblastoma to the prostate gland in transgenic mice.

Authors:  D G Skalnik; D M Dorfman; D A Williams; S H Orkin
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

10.  Regulation of expression of transgenes in developing fish.

Authors:  B Moav; Z Liu; L D Caldovic; M L Gross; A J Faras; P B Hackett
Journal:  Transgenic Res       Date:  1993-05       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.